We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- COVID-19 (127)
- COVID-19 vaccines (80)
- Advertising (77)
- Prescription medicines (33)
- Regulatory compliance (19)
- Alert/Advisory (15)
- Medicines safety (15)
- Safety (7)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Labelling and packaging (3)
- Over the counter (OTC) medicines (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Shortages (2)
- Cosmetics (1)
- Import and export (1)
- Listed medicines (1)
- Medicinal cannabis hub (1)
- Non-prescription medicines (1)
- Scheduling (national classification system) (1)
Results for
"[search-keyword]"
Collection content
308 result(s) found, displaying 201 to 210
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Safety alertsThird Australian case of thrombosis with thrombocytopenia likely linked to vaccine
-
NewsThe granting of a provisional determination means that the TGA has made a decision that GSK is now eligible to apply for provisional registration for the treatment in the Australian Register of Therapeutic Goods.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Safety alertsSecond case of thrombosis with thrombocytopenia
-
Media releasesUpdated safety advisory - rare and unusual blood clotting syndrome (thrombosis with thrombocytopenia)
-
NewsUpdated storage conditions for the Pfizer COVID-19 vaccine
-
Media releasesTGA has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Media releasesSome rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.